http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4859674-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6e2ebfcf2ba03f4bda3c77fc77f645c |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
filingDate | 1988-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1989-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e6af03185dd0f0ffe47fd731e38d091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c0d194b8087ef1178849b557fce709d |
publicationDate | 1989-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4859674-A |
titleOfInvention | Pyrazine in prevention and treatment of strokes |
abstract | Neurologic dysfunction resulting from stroke is diminished by administering to a patient an effective amount of a tetra-substituted pyrazine over a relatively continuous regimen. Conveniently, an initial bolus is administered to bring the level of the drug up to a pre-determined blood level, followed by continuous infusion employing a pump or by continuous intravenous infusion. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10604467-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364202-B2 |
priorityDate | 1987-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.